Relevant bibliographies by topics / LGD-4033

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters

Academic literature on the topic 'LGD-4033'

Author: Grafiati
Published: 4 June 2021
Last updated: 7 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'LGD-4033.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "LGD-4033"

1

Barbara, Mary, Sadhna Dhingra, and Ayse L. Mindikoglu. "Ligandrol (LGD-4033)-Induced Liver Injury." ACG Case Reports Journal 7, no. 6 (2020): e00370. http://dx.doi.org/10.14309/crj.0000000000000370.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fragkaki, Argyro G., Panagiotis Sakellariou, Polyxeni Kiousi, et al. "Human in vivo metabolism study of LGD‐4033." Drug Testing and Analysis 10, no. 11-12 (2018): 1635–45. http://dx.doi.org/10.1002/dta.2512.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Fragkaki, Argyro G., Panagiotis Sakellariou, Polyxeni Kiousi, et al. "Human in vivo metabolism study of LGD‐4033." Drug Testing and Analysis 12, no. 1 (2019): 164. http://dx.doi.org/10.1002/dta.2700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cox, Holly D., and Daniel Eichner. "Detection of LGD-4033 and its metabolites in athlete urine samples." Drug Testing and Analysis 9, no. 1 (2016): 127–34. http://dx.doi.org/10.1002/dta.1986.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Geldof, Lore, Oscar J. Pozo, Leen Lootens, Wouter Morthier, Peter Van Eenoo, and Koen Deventer. "In vitro metabolism study of a black market product containing SARM LGD-4033." Drug Testing and Analysis 9, no. 2 (2016): 168–78. http://dx.doi.org/10.1002/dta.1930.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kintz, Pascal, Alice Ameline, Laurie Gheddar, and Jean-Sébastien Raul. "LGD-4033, S-4 and MK-2866 – Testing for SARMs in hair: About 2 doping cases." Toxicologie Analytique et Clinique 31, no. 1 (2019): 56–63. http://dx.doi.org/10.1016/j.toxac.2018.12.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hansson, Annelie, Heather Knych, Scott Stanley, et al. "Equine in vivo -derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites." Journal of Chromatography B 1074-1075 (February 2018): 91–98. http://dx.doi.org/10.1016/j.jchromb.2017.12.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barbara, Mary, Sadhna Dhingra, and Ayse L. Mindikoglu. "Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033)." ACG Case Reports Journal 7, no. 6 (2020): e00409. http://dx.doi.org/10.14309/crj.0000000000000409.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Basaria, Shehzad, Lauren Collins, E. Lichar Dillon, et al. "The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men." Journals of Gerontology: Series A 68, no. 1 (2010): 87–95. http://dx.doi.org/10.1093/gerona/gls078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cutler, Charlotte, Marjaana Viljanto, Pamela Hincks, Jocelyn Habershon‐Butcher, Tessa Muir, and Simon Biddle. "Investigation of the metabolism of the selective androgen receptor modulator LGD‐4033 in equine urine, plasma and hair following oral administration." Drug Testing and Analysis 12, no. 2 (2020): 247–60. http://dx.doi.org/10.1002/dta.2719.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "LGD-4033"

1

Liora, Jackson. "Characterization of the equine metabolites of LGD-4033 in urine using UHPLC-MS(/MS) for doping control purposes." Thesis, Uppsala universitet, Avdelningen för analytisk farmaceutisk kemi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-327185.

Full text
Abstract:
The aim of this project was to study and characterize the metabolitesof LGD-4033 in equine urine, with the final aim of using the results indoping controls in equestrian sports. Urine samples had been taken atdifferent points in time from three horses that had received thesubstance intravenously. The samples were both directly analysed usinga so called dilute-and-shoot approach and were also prepared with amixed mode anion exchange solid phase extraction. All analysis weredone with UHPLC-ESI-MS(/MS) in negative mode. A total of eightmetabolites were found, which were all combinations of phase
APA, Harvard, Vancouver, ISO, and other styles
2

Berndtson, Emma. "Qualitative analysis of LGD-4033 and its metabolites in equine plasma using UHPLC-MS(MS) for doping control purposes." Thesis, Uppsala universitet, Analytisk kemi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-327256.

Full text
Abstract:
A new class of drugs has been developed for treatment of muscle and bone mass wasting diseases called non-steroidal selective androgen receptor modulators (SARMs). Because of their positive androgenic effects such as muscle gain, they are desirable as performance enhancers. One of those substances is LGD-4033 (4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)- benzonitrile). It has been detected in human samples in routine doping control and another SARM has been detected in an equine blood sample in routine doping control. It is therefore indicated that SARMs
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "LGD-4033"

1

Basaria, Shehzad, Lauren Collins, Melinda Sheffield-Moore, et al. "Safety and Tolerability of LGD-4033, a Novel Non-Steroidal Oral Selective Androgen Receptor Modulator (SARM), in Healthy Men." In CLINICAL - Male Reproductive Endocrinology II & Case Reports. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part3.p27.p3-207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Marschke, KB, A. van Oeveren, MH Hong, J. Sanders, EG Vajda, and L. Zhi. "Binding of the SARM LGD-4033 Induces Specific Conformational Changes in the AR-LBD and Exhibits a Unique Protein-Protein Interaction Profile Distinct from Steroidal Androgen Agonists and Other SARMs." In The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part1.or.or01-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography